A Study of Fibrocaps in Liver Surgery in the Netherlands
- Conditions
- Postoperative Hemorrhage
- Interventions
- Biological: Fibrocaps (fibrin sealant)Device: Gelatin sponge
- First Posted Date
- 2010-12-08
- Last Posted Date
- 2016-08-22
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 56
- Registration Number
- NCT01256190
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel
- Conditions
- Pain
- Interventions
- Drug: 2% w/w diclofenac sodium topical gelDrug: 1.5% w/w diclofenac sodium topical solutionDrug: 75 mg diclofenac sodium delayed release tablet
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2014-09-23
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 30
- Registration Number
- NCT01202799
- Locations
- 🇺🇸
Comprehensive Phase One, Miramar, Florida, United States
Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.
- Conditions
- Pain
- Interventions
- Drug: Test fentanyl citrate 400 mcg troche
- First Posted Date
- 2010-08-02
- Last Posted Date
- 2016-10-19
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 50
- Registration Number
- NCT01173627
- Locations
- 🇺🇸
PRACS Institute, Ltd, Fargo, North Dakota, United States
A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin
- First Posted Date
- 2010-06-14
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 196
- Registration Number
- NCT01143246
- Locations
- 🇺🇸
Scripps Clinic, La Jolla, California, United States
🇺🇸University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States
🇺🇸Iowa City VA Health Care System, Iowa City, Iowa, United States
Exploratory Study of PENNSAID Gel to Treat Symptoms of Knee Osteoarthritis
- First Posted Date
- 2010-05-10
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 260
- Registration Number
- NCT01119898
- Locations
- 🇺🇸
Clinical Trials Technology, Inc., Prairie Village, Kansas, United States
🇺🇸Crescent Medical Research, Salisbury, North Carolina, United States
🇺🇸Palmetto Medical Research, Mount Pleasant, South Carolina, United States
IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction
- Conditions
- ST-Segment Elevation Myocardial Infraction
- Interventions
- Drug: Sodium Sulfide (Na2S) for InjectionDrug: Placebo
- First Posted Date
- 2009-11-04
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- Mallinckrodt
- Registration Number
- NCT01007461
Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors
- First Posted Date
- 2009-07-23
- Last Posted Date
- 2016-09-09
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 150
- Registration Number
- NCT00944372
- Locations
- 🇺🇸
University of Miami, Jackson Memorial Hospital, Miami, Florida, United States
🇺🇸University of Iowa Medical Center, Iowa City, Iowa, United States
🇺🇸Louisiana State University, Division of Hem/Onc, New Orleans, Louisiana, United States
Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Drug: PlaceboDrug: Inhaled Nitric Oxide
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2017-12-04
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 451
- Registration Number
- NCT00931632
- Locations
- 🇺🇸
Saint Francis Children's Hospital, Tulsa, Oklahoma, United States
🇺🇸Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States
🇺🇸Winnie Palmer Hospital for Women and Babies, Orlando, Florida, United States
Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure
- Conditions
- Hypoxic Respiratory Failure With Pulmonary Hypertension
- Interventions
- Drug: Inhaled Nitric OxideDrug: Placebo
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2016-09-09
- Lead Sponsor
- Mallinckrodt
- Registration Number
- NCT00922532
Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function
- First Posted Date
- 2009-04-10
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- Mallinckrodt
- Target Recruit Count
- 28
- Registration Number
- NCT00879645
- Locations
- 🇺🇸
DaVita Clinical Research, Minneapolis, Minnesota, United States